Navigation Links
Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally.

Researchers have explained that the killer disease of H.Influenza could be virtually abolished in Africa by routinely vaccinating the infants Hib vaccine. //

Scientists from the Oxford University have shown in their research that the routine vaccination of infants in Kenya against H. influenza Type b (Hib) significantly reduced invasive Hib disease to 88% below baseline. The researchers had published their findings in the Journal of the American Medical Association (JAMA) on the 9th August

Dr. Anthony Scott, the lead author of the paper that was titled, ‘Effectiveness of Haemophilus influenza Type b (Hib) Conjugate Vaccine Introduction into Routine Childhood Immunization in Kenya’, explained that after three years of introduction, Hib vaccination was responsible for:
Reducing laboratory-confirmed invasive Hib disease by 88% from pre-vaccine levels.
Preventing an estimated 3,370 hospitalisations in Kenya in 2005.

Commenting on the study, Karen Cowgill, lead author and, at the time of the study, Epidemic Intelligence Service officer at the Centres for Disease Control and Prevention in the US, said: "These results demonstrate the effectiveness of the Hib vaccine in reducing severe childhood illness and associated deaths in Kenya, and lead us to conclude that many more deaths could be averted in Africa if more countries were to adopt the vaccine as part of their national EPI programs."

This is the first published study in East Africa to document the significant benefit of routine Hib vaccination in protecting young children against the devastating effects of a leading cause of childhood meningitis and pneumonia. The findings build on a considerable body of growing evidence from Africa and around the world: similar results have been observed in The Gambia, Chile, the US, and UK. The findings contained within the study can reasonably be expected to apply to other African settings too.

Recently, a numbe r of developing countries have begun routinely vaccinating children against Hib disease. Yet despite the overwhelming evidence and support in favour of these vaccines, less than 40% of African countries have adopted the Hib vaccine. One major obstacle has been the lack of available data on Hib disease burden and vaccine effectiveness.

“It is vital to support public health interventions such as the introduction of Hib vaccine with hard evidence,” said Dr. Sharif, Deputy Director of Medical Services within the Ministry of Health, Kenya. “The strength of our surveillance systems will also assist us with the evaluation of new vaccines to prevent other leading child killers such as pneumococcus and rotavirus,” he added.

Worldwide, Hib disease is estimated to cause 3 million episodes of serious disease among children each year, leading to 400,000 deaths. The greatest burden of disease and death occurs in Africa. If countries, donors and industry can be mobilized to introduce Hib vaccine into the countries that need it the most, the parents, children and healthcare providers in Africa could see the same virtual elimination of this devastating disease as seen in industrialized countries.

Surveillance to monitor the impact of health and vaccination programs is essential. “Building the evidence base for the introduction of new and underused life-saving vaccines is a critical step in understanding what interventions countries need to save more lives faster,” said Julian Lob-Levyt, Executive Secretary, GAVI Alliance. “If you can measure the impact a disease is having on your country, it is easier to build the case for preventing it.” he added.

The GAVI Alliance, together with partners and stakeholders in Kenya and other developing countries, is working collaboratively to provide funding for vaccine programs and to implement programs to improve health systems and strengthen surveillance networks.

This study further supp orts the WHO's Strategic advisory Group of Experts (SAGE) and Africa's Task Force on Immunization's recommendations for global implementation of Hib vaccine and suggests that routine use could help reach the Millennium Development Goal of reducing child mortality by two-thirds by 2015.

Source: EuekAlert
'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: